Holen Sie sich die Stockscreener-App
4.69
5.39%
0.24
Schlusskurs vom Vortag:
$4.45
Offen:
$4.45
24-Stunden-Volumen:
230.12K
Relative Volume:
0.73
Marktkapitalisierung:
$87.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-41.59%
1M Leistung:
+20.57%
6M Leistung:
-35.13%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.29
$4.98
1-Wochen-Bereich:
$4.29
$8.445
52-Wochen-Spanne:
$2.14
$12.50
Kalaris Therapeutics Inc Stock (KLRS) Company Profile
Firmenname
Kalaris Therapeutics Inc
Sektor
Branche
Telefon
650-249-2727
Adresse
628 MIDDLEFIELD ROAD, PALO ALTO
Vergleichen Sie KLRS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KLRS
Kalaris Therapeutics Inc
|
4.69 | 83.23M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Kalaris Therapeutics Inc Stock (KLRS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-07-23 | Fortgesetzt | Piper Sandler | Neutral |
| 2025-05-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-08 | Eingeleitet | William Blair | Outperform |
Kalaris Therapeutics Inc Aktie (KLRS) Neueste Nachrichten
Is Kalaris Therapeutics Inc. stock positioned for digital transformationWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com
Published on: 2025-10-13 07:20:53 - newser.com
Candlestick signals on Kalaris Therapeutics Inc. stock todayJuly 2025 Movers & Reliable Entry Point Alerts - newser.com
Published on: 2025-10-13 00:54:13 - newser.com
Identifying reversal signals in Kalaris Therapeutics Inc.2025 Market Overview & Breakout Confirmation Alerts - newser.com
Real time breakdown of Kalaris Therapeutics Inc. stock performanceQuarterly Profit Summary & Low Drawdown Trading Techniques - newser.com
Is Kalaris Therapeutics Inc. building a consolidation base2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
Kalaris Therapeutics (NASDAQ:KLRS) Receives "Sell (E)" Rating from Weiss Ratings - MarketBeat
Custom watchlist performance reports with Kalaris Therapeutics Inc.Market Trend Summary & Daily Momentum Trading Reports - newser.com
Price action breakdown for Kalaris Therapeutics Inc.July 2025 Big Picture & Accurate Intraday Trading Signals - newser.com
Has Kalaris Therapeutics Inc. found a price floorJuly 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com
Wall Street Zen Upgrades Kalaris Therapeutics (NASDAQ:KLRS) to Hold - Defense World
Kalaris Therapeutics (NASDAQ:KLRS) Upgraded at Wall Street Zen - MarketBeat
Kalaris Therapeutics Inc. (NASDAQ:KLRS) Short Interest Update - MarketBeat
Building trade automation scripts for Kalaris Therapeutics Inc.Market Activity Recap & Precise Entry and Exit Recommendations - newser.com
Kalaris Therapeutics Inc Stock Analysis and ForecastSupport and Resistance Levels & Free Realize Exceptional Returns - earlytimes.in
Kalaris Therapeutics (KLRS) Price Target Increased by 33.33% to 15.64 - Nasdaq
What drives Kalaris Therapeutics Inc stock priceResistance Zone Identification & Our Experts Decode Market Noise for You - earlytimes.in
Kalaris Therapeutics, Inc.'s (NASDAQ:KLRS) biggest owners are private equity firms who got richer after stock soared 24% last week - Yahoo Finance
Private equity firms in Kalaris Therapeutics, Inc. (NASDAQ:KLRS) are its biggest bettors, and their bets paid off as stock gained 24% last week - simplywall.st
What analysts say about Kalaris Therapeutics Inc stockInsider Trading Compliance & Free High Velocity Capital Growth - earlytimes.in
Why SLDP stock remains resilientQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
How to use Fibonacci retracement on Kalaris Therapeutics Inc.Weekly Investment Summary & Real-Time Market Sentiment Reports - newser.com
Jalen Brunson Opens Up on Knicks Role Shift Under Mike Brown - Berawang News
Short interest data insights for Kalaris Therapeutics Inc.2025 Stock Rankings & Real-Time Chart Pattern Alerts - newser.com
has kalaris therapeutics inc. found a price floorWeekly Stock Report & Low Volatility Stock Recommendations - newser.com
Published on: 2025-09-22 09:09:39 - newser.com
What candlestick patterns are forming on Kalaris Therapeutics Inc.2025 Investor Takeaways & Real-Time Chart Breakout Alerts - newser.com
Kalaris enrolling phase 1b/2 study of TH103 for nAMD - Modern Retina
Measuring Kalaris Therapeutics Inc.’s beta against major indicesEarnings Beat & Target Return Focused Picks - newser.com
Technical signs of recovery in Kalaris Therapeutics Inc.2025 Major Catalysts & Breakout Confirmation Trade Signals - newser.com
Wall Street Recap: Should you avoid Kalaris Therapeutics Inc stock right nowProfit Target & Safe Swing Trade Setup Alerts - خودرو بانک
Earnings Risk: Is Kalaris Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Moving Averages: Is Kalaris Therapeutics Inc. a speculative investmentWeekly Trade Recap & Community Trade Idea Sharing - خودرو بانک
Take Profit: Is YCBD a turnaround storyJuly 2025 Catalysts & Safe Entry Trade Signal Reports - khodrobank.com
Long term hold vs stop loss in Kalaris Therapeutics Inc.July 2025 Drop Watch & Daily Stock Trend Reports - newser.com
Will Kalaris Therapeutics Inc. benefit from macro trends2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - newser.com
CEO Moves: Is Digi International Inc stock a value trapJuly 2025 Retail & Weekly Hot Stock Watchlists - khodrobank.com
Market Trends: Is Kalaris Therapeutics Inc. a strong candidate for buy and holdQuarterly Earnings Report & Free Community Consensus Stock Picks - خودرو بانک
Applying chart zones and confluence areas to Kalaris Therapeutics Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
MACD Signal: Should you avoid Kalaris Therapeutics Inc stock right nowIPO Watch & Long Hold Capital Preservation Tips - خودرو بانک
What the charts say about Kalaris Therapeutics Inc. today2025 Market Trends & Fast Entry Momentum Trade Alerts - newser.com
Volume spikes in Kalaris Therapeutics Inc. stock – what they mean2025 Investor Takeaways & Long-Term Safe Investment Plans - newser.com
Chart based exit strategy for Kalaris Therapeutics Inc.2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Using RSI to spot recovery in Kalaris Therapeutics Inc.2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com
Visual trend scoring systems applied to Kalaris Therapeutics Inc.July 2025 Volume & Free Community Consensus Stock Picks - newser.com
Finanzdaten der Kalaris Therapeutics Inc-Aktie (KLRS)
Es liegen keine Finanzdaten für Kalaris Therapeutics Inc (KLRS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):